Transcranial Doppler Market: Global Industry Analysis And Forecast (2023-2029)

Transcranial Doppler Market size was valued at US$ 281.85 Mn. in 2022 and the total Transcranial Doppler revenue is expected to grow at 4.2% through 2023 to 2029, reaching nearly US$ 375.93 Mn.
Transcranial Doppler Market Overview:
Transcranial Doppler ultrasonography is a painless diagnostic that examines blood flow in the brain using sound waves. This test is recommended by doctors to detect a medical problem that affects blood flow to and inside the brain. The test is also used to track the effectiveness of some therapies, such as the dissolution of blockages inside brain arteries. Sound waves are transmitted through the cranial tissues during the test. These sound waves ricochet off moving blood cells within blood arteries, enabling the physician or neurologist to determine their velocity and distance. Acoustic waves are captured and presented on a computer monitor.



To know about the Research Methodology:- Request Free Sample Report

With the introduction of thrombolytic therapy for acute ischemic stroke, the physician would likely benefit from the knowledge of transcranial Doppler ultrasonography, which is a powerful technique for detecting cerebral vascular blockage. This test can also be used to measure the efficacy of thrombolytic therapy.

In this Transcranial Doppler market report, the Transcranial Doppler market's growth reasons, as well as the market's many segments (Equipment Type, End-User, Application, Display Mode, Mode Type, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, info graphics, and presentations. The study discusses the Transcranial Doppler market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global Transcranial Doppler market situation.
Dynamics:
One of the primary trends observed in the global transcranial doppler market is technological improvement. Manufacturers are producing transportable, compact, and flexible transcranial dopplers as an example of technical innovation in response to the increased need for portable systems. By monitoring blood flow rate in the brain and identifying stenosis and emboli, the gadget provides comprehensive diagnostic options for a contemporary neurovascular facility. As a result of technical improvement, the availability of such a diverse variety of transcranial doppler systems is projected to contribute to market growth in the forecast period.

The upsurge in neurological disorders, with approximately 1 million individuals facing head trauma each year, is a critical factor ramping up the market growth, as is the capacity to use it for varying ages, sexual orientations, hypertension, and various movement disorders, the rise in the implementation of this model for evaluating cerebral hemodynamic and diagnosing cerebrovascular abnormalities, and the upsurge in the aging populations, among others, are the key factors that drive the market.

The high cost of neurological surgical procedures and instruments is a key impediment to the Transcranial Doppler industry, particularly in underdeveloped countries with inadequate compensation regulations. In the United States, the estimated price of routine operations to treat aneurysms and artery problems ranges between US$ 40,000 and US$ 55,000. Furthermore, maintenance charges and other accompanying incidental costs raise the overall ownership costs of such devices, restricting their acceptance. Due to economic restrictions, small hospitals and freestanding treatment centers are less likely to invest in costly and complex equipment; this is especially prevalent in underdeveloped nations. Because of the high prices and inadequate reimbursement scenario, only a small number of patients in poorer nations can afford neurological therapy. As a result, healthcare institutions are hesitant to invest in new or sophisticated technology systems, inhibiting market growth.
Transcranial Doppler Market Segment Analysis:
By Application, the Sickle disease segment is expected to grow at a CAGR of 2.8% in the aforementioned forecast period. This ultrasound method is more likely to be used by people who have sickle cell disease. This is a genetic blood illness marked by malformed, stiff, sickle-shaped red blood cells resulting from mutations. According to the National Institute of Health, sickle cell illnesses are by far the most frequent hereditary illnesses in the U. S., afflicting over 72,530 people, prompting the intended client group to embrace transcranial doppler ultrasonography for disease detection. The intended population's growing demands for transcranial Doppler systems for routine monitoring are expected to drive the segment growth.



Furthermore, with a rising number of neurological illnesses globally, there could be an increase in the use of this system for measuring cerebral tissue perfusion and diagnosing cerebral disorders, promoting the entire market's growth.
Transcranial Doppler Market Regional Insights:
After the forecast period, North America is expected to be the largest market for transcranial dopplers in neurology. The North American market is primarily driven by factors such as an increasing target patient group for peripheral nerve diseases, greater awareness among brain surgeons about the advantages of interventional neurophysiology devices, and continuing social programs to modernize and expand the healthcare system.

According to a 2021 CDC estimate, roughly 150,000 Americans die each year from neurological disorders such as stroke. According to the CDC, one person dies every five minutes and one person suffers a stroke every 35 seconds in the U. S. Transcranial doppler ultrasonography can determine the hazards of stroke and microscopic emboli, which is expanding its use.

Brain surgeons and other medical experts are extremely interested in treatment options that might successfully lower the risk of mortality or severity of peripheral nerve illnesses in patients. With an increasing number of people suffering from nerve diseases (e.g. epilepsy, stroke, and aneurysm) and the intensity of medical conditions (e.g. hemorrhage and other infections) in intended patients, the need for nerve treatments is increasing all over key markets e.g. the United States, UK, Canada, Germany, Japan, China, and India.

The objective of the report is to present a comprehensive analysis of the Transcranial Doppler market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Transcranial Doppler market dynamics, structure by analyzing the market segments and projecting the Transcranial Doppler market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Transcranial Doppler market make the report investor’s guide.
Transcranial Doppler Market Scope: Inquire before buying



Transcranial Doppler Market


Base Year
2022
Forecast Period
2023-2029


Historical Data
CAGR
Market Size in 2022
Market Size in 2029


2018 to 2022
4.2%
US$ 281.85 Mn
US$ 375.93 Mn


Segments Covered


by Equipment Type
Imaging
Non-Imaging
by Application
Sickle Cell Disease
Acute Ischemic Stroke
Intracranial Steno Occlusive Disease
Micro Emboli Detection
by Display Mode
B-Mode
M-Mode
by End-user
Hospitals
Diagnostics
Others
by Mode Type
Portable
Standalone


Regions Covered


North America
United States
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Sweden
Austria
Rest of Europe
Asia Pacific
China
S Korea
Japan
India
Australia
Indonesia
Malaysia
Vietnam
Taiwan
Bangladesh
Pakistan
Rest of APAC
Middle East and Africa
South Africa
GCC
Egypt
Nigeria
Rest of ME&A
South America
Brazil
Argentina
Rest of South America



Transcranial Doppler Market Key Players
1. Integra LifeSciences
2. Spiegelberg GmbH & Co.
3. Nihon Kohden Corporation
4. Elekta
5. Rimed Ltd
6. Grass Technologies
7. CAS Medical System
8. Yokogawa electric
9. Cadwell Laboratories
10.Natus Medical
11.Covidien
12.Rimed Ltd.
13.Atys Medical
14.Delica
FAQs:
1. Which is the potential market for the Transcranial Doppler in terms of the region?
Ans. North America is expected to be the largest market for transcranial dopplers in neurology.

2. What are the opportunities for new market entrants?
Ans. The upsurge in neurological disorders, with approximately 1 million individuals facing head trauma each year

3. What is expected to drive the growth of the Transcranial Doppler market in the forecast period?
Ans. One of the primary trends observed in the global transcranial doppler market is a technological improvement.

4. What is the projected market size & growth rate of the Transcranial Doppler Market?
Ans. Transcranial Doppler Market size was valued at US$ 281.85 Mn. in 2022 and the total Transcranial Doppler revenue is expected to grow at 4.2% through 2023 to 2029, reaching nearly US$ 375.93 Mn.

5. What segments are covered in the Transcranial Doppler Market report?
Ans. The segments covered are Equipment Type, End-User, Application, Display Mode, Mode Type, and Region.